ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267505.1	Ponatinib	Bladder urothelial carcinoma	0.045473753	Resistant
ENSG00000267505.1	Ponatinib	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.040439825	Sensitive